Trimetazidine is an anti-ischemic metabolic agent widely indicated for the management of angina pectoris, working by enhancing myocardial oxygen utilization through the inhibition of fatty acid oxidation.… Read more
















































Trimetazidine is an anti-ischemic metabolic agent widely indicated for the management of angina pectoris, working by enhancing myocardial oxygen utilization through the inhibition of fatty acid oxidation. For pharmaceutical laboratories, this category offers a comprehensive range of high-quality reference standards essential for rigorous analytical testing and quality control. The collection includes pharmacopeial and non-pharmacopeial impurities, degradation products, and synthetic intermediates critical for accurate impurity profiling and method validation. Additionally, researchers can utilize stable isotope labelled compounds to ensure precision in mass spectrometry-based assays and pharmacokinetic studies. By employing these characterized standards, laboratories can maintain compliance with strict regulatory requirements, ensuring that every batch of the drug meets established safety and efficacy profiles during the manufacturing and development lifecycle.